These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29505190)

  • 1. Evidence-Based Strategies for Managing Tardive Dyskinesia.
    McEvoy JP
    J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29505190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options.
    Manning JS; McEvoy JP
    J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29505191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excoriation disorder as a risk factor for deep brain stimulation hardware removal.
    Calandrella D; Rizzi M; Ferré FM; Romito LM
    J Neurol Sci; 2017 Feb; 373():342-343. PubMed ID: 28131218
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparing Treatments for Tardive Dyskinesia.
    Citrome LL
    J Clin Psychiatry; 2017; 78(9):e1429. PubMed ID: 29345877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS; Sauvanaud F; Limosin F
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of state-dependent reversal of tardive dyskinesia: phenomenological probe in humans.
    Goswami U; Narayanan HS; Channabasavanna SM
    J Clin Psychopharmacol; 1985 Feb; 5(1):48-50. PubMed ID: 2857733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium monotherapy-induced tardive dyskinesia.
    Fountoulakis KN; Tegos T; Kimiskidis V
    J Affect Disord; 2019 Feb; 244():78-79. PubMed ID: 30321768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-VMAT2 inhibitor treatments for the treatment of tardive dyskinesia.
    Lin CC; Ondo WG
    J Neurol Sci; 2018 Jun; 389():48-54. PubMed ID: 29433806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep brain stimulation of the internal globus pallidus for disabling haloperidol-induced tardive dystonia. Report of two cases.
    Sobstyl M; Ząbek M; Mossakowski Z; Zaczyński A
    Neurol Neurochir Pol; 2016; 50(4):258-61. PubMed ID: 27375139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilizing the concept of geste antagoniste for conservative management of oro-mandibular tardive dyskinesia: a case report and mini-review.
    Farag AM; Mier RW; Correa LP
    Cranio; 2016 Sep; 34(5):338-42. PubMed ID: 26293144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorder.
    McIntyre RS; Calabrese JR; Nierenberg AA; Farahmand K; Yonan C; Siegert S; Burke J
    J Affect Disord; 2019 Mar; 246():217-223. PubMed ID: 30583148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dramatic improvement of tardive dyskinesia movements by inline skating.
    Casagrande SCB; Cury RG; de Lima-Pardini AC; Coelho DB; Souza CO; Dos Santos Ghilardi MG; Silveira-Moriyama L; Teixeira LA; Barbosa ER; Fonoff ET
    Neurology; 2017 Jul; 89(2):211-213. PubMed ID: 28696930
    [No Abstract]   [Full Text] [Related]  

  • 13. Tardive Dyskinesia Should Not Be Overlooked.
    Kakko K; Bjelogrlic-Laakso N; Pihlakoski L; Lehtimäki K; Järventausta K
    J Child Adolesc Psychopharmacol; 2019 Feb; 29(1):72-74. PubMed ID: 30388034
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia.
    Vijayakumar D; Jankovic J
    Drugs; 2016 May; 76(7):779-87. PubMed ID: 27091214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic-induced Tardive dyskinesia: from biological basis to clinical management.
    Salem H; Pigott T; Zhang XY; Zeni CP; Teixeira AL
    Expert Rev Neurother; 2017 Sep; 17(9):883-894. PubMed ID: 28750568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antipsychotic-induced tardive syndromes].
    Fleischhacker WW; Hofer A; Jagsch C; Pirker W; Psota G; Rittmannsberger H; Seppi K
    Neuropsychiatr; 2016 Sep; 30(3):123-130. PubMed ID: 27580887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurostimulation in tardive dystonia/dyskinesia: A delayed start, sham stimulation-controlled randomized trial.
    Gruber D; Südmeyer M; Deuschl G; Falk D; Krauss JK; Mueller J; Müller JU; Poewe W; Schneider GH; Schrader C; Vesper J; Volkmann J; Winter C; Kupsch A; Schnitzler A;
    Brain Stimul; 2018; 11(6):1368-1377. PubMed ID: 30249417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for tardive dyskinesia according to primary psychiatric diagnosis.
    Wolf ME; DeWolfe AS; Mosnaim AD
    Hillside J Clin Psychiatry; 1987; 9(1):3-11. PubMed ID: 2888712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-morbid obsessive compulsive and hypochondriac disorders complicated by tardive dyskinesia in a Nigerian man.
    Aghukwa NC
    Niger J Clin Pract; 2016; 19(1):145-9. PubMed ID: 26755234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.